Altered gene expression for calpain/calpastatin system in motor neuron degeneration (Mnd) mutant mouse brain and spinal cord

Molecular Brain Research

Volumn 53, Issue 1-2, 1998, Pages 174-186

  Li, Jinhe ^a,b   Nixon, Ralph ^a,b   Messer, Anne ^a,b   Berman, Stephen ^a,b   Bursztajn, Sherry ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Calpain; Calpastatin; Hippocampus; In situ hybridization; Mnd mice; Spinal cord

Indexed keywords

CALPAIN; CALPASTATIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; FEMALE; GRANULE CELL; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; MALE; MOTONEURON; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; PYRAMIDAL NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD;

ANIMALIA;

EID: 0031950957     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00295-7     Document Type: Article

References (42)

1. Bronson R.T., Lake B.D., Cook S., Taylor S., Davisson M.T. Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease). Ann. Neurol. 33:1993;381-385.
2. Bursztajn S., Berman S.A., Gilbert W. Differential expression of acetylcholine receptor mRNA in nuclei of cultured muscle cells. Proc. Natl. Acad. Sci. USA. 86:1989;2928-2932.
3. Callahan L.M., Wylen E.L., Messer A., Mazurkiewicz J.E. Neurofilament distribution is altered in the Mnd (motor neuron degeneration) mouse. J. Neuropathol. Exp. Neurol. 50:1991;491-504.
4. G. Clark (1981) in: Staining Procedures, Williams and Wilkins, Baltimore, MD, pp. 147-148.
5. Croall D.E., DeMartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. [Review]. Physiol. Rev. 71:1991;813-847.
6. DeLuca C.I., Davies P.L., Samis J.A., Elce J.S. Molecular cloning and bacterial expression of cDNA for rat calpain II 80 kDa subunit. Biochim. Biophys. Acta. 1216:1993;81-93.
7. Faust J.R., Rodman J.S., Daniel P.F., Dice J.F., Bronson R.T. Two related proteolipids and dolichol-linked oliogsaccharides accumulate in motor neuron degeneration mice (mnd/mnd), a model for neuronal ceroid lipofuscinosis. J. Biol. Chem. 269:1994;10150-10155.
8. F. Grynspan, W.R. Griffin, A. Cataldo, S. Katayama and R.A. Nixon (1997) Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res. in press.
9. Hasel K.W., Glass J.R., Godbout M., Sutcliffe J.G. An endoplasmic reticulum- specific cyclophilin. Mol. Cell. Biol. 11:1991;3484-3491.
10. Johnson P. Calpains (intracellular calcium-activated cystein proteases): structural-activity relationships and involvement in normal and abnormal cellular metabolism. Int. J. Biochem. 22:1990;811-822.
11. Lee K.S., Frank S., Vanderklish P., Arai A., Lynch G. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl. Acad. Sci. USA. 88:1991;7233-7237.
12. Lee W.J., Hatanaka M., Maki M. Multiple forms of rat calpastatin cDNA in the coding region of functionally unknown amino-terminal domain. Biochim. Biophys. Acta. 1129:1992;251-253.
13. Li J., Grynspan F., Berman S.A., Guo M., Nixon R.A., Bursztajn S. Differential gene expression for the calcium dependent protease (Calpain) system during aging in the mouse central nervous system. J. Neurobiol. 30:1996;177-191.
14. Li J., Berman S.A., Guo M., Nixon R.A., Bursztajn S. Differential gene expression for the calcium dependent proteases (calpain) system during aging in the mouse central nervous system. Soc. Neurosci. Abst. 20:1994;882.
15. Lynch G., Baudry M. Brain spectrin, calpain and long-term changes in synaptic efficacy. [Review]. Brain Res. Bull. 18:1987;809-815.
16. Mazurkiewicz J.E. Ubiquitin deposits are present in spinal motor neurons in all stages of the disease in the motor neuron degeneration (Mnd) mutant of mouse. Neurosci. Lett. 128:1991;182-186.
17. R.L. Mellgren, and T. Murachi (1990) Intracellular Calcium-dependent Proteolysis. CRC Press, Boca Raton, FL.
18. Messer A., Flaherty L. Autosomal dominance in a late-onset motor neuron disease in mouse. J. Neurogenet. 3:1986;345-355.
19. Messer A., Plummer J., Maskin P., Coffin J.M., Frankel W.N. Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS). Genomics. 18:1992;797-802.
20. Messer A., Plummer J., Wong V., Lavail M.M. Retinal degeneration in motor neuron degeneration (mnd) mutant mice. Exp. Eye Res. 57:1993;637-641.
21. Messer A., Strominger N.L., Mazurkiewicz J.E. Histopathology of the late-onset motor neuron degeneration (Mnd) mutant in mouse. J. Neurogenet. 4:1987;201-213.
22. Minami N., Tani E., Maeda Y., Yamaura I., Fukami M. Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasm. J. Neurosurg. 76:1992;111-118.
23. Murachi T. Intracellular regulatory system involving calpain and calpastatin. Biochem. Int. 18:1989;263-294.
24. Murphy G.M. Jr., Jia X.C., Yu A.C., Lee Y.L., Tinklenberg J.R., Eng L.F. Reverse transcription and polymerase chain reaction technique for quantification of mRNA in primary astrocyte cultures. J. Neurosci. Res. 35:1993;643-651.
25. Nixon R.A., Clarke J.F., Logvinenko K.B., Tan M.K., Hoult M., Grynspan F. Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes. J. Neurochem. 55:1990;1950-1959.
26. Nixon R.A., Saito K.I., Grynspan F., Griffin W.R., Katayama S., Honda T., Mohan P.S., Shea T.B., Beermann M. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. NY Acad. Sci. 747:1994;77-91.
27. Pardo C.A., Rabin B.A., Palmer D.N., Price D.L. Accumulation of the adenosine triphosphate synthase subunit c in the mnd mutant mice. A model for neuronal ceroid lipofuscinosis. Am. J. Pathol. 144:1994;1-7.
28. Perl D.P., Brody A.R. Alzheimer's disease: X-ray spectrametric evidence of aluminium accumulation in neurofibrillary tangle-bearing neurons. Science. 208:1980;297-299.
29. Perl D.P., Gajdusek D.C., Garruto R.M., Yanagihara R.T., Gibbs C.J. Jr. Intraneuronal aluminium accumulation in amyotrophic lateral sclerosis and Parkinsonism dementia of Guam. Science. 217:1982;1053-1055.
30. Price T., Aitken J., Simpson E.R. Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification. J. Clin. Endocrinol. Metab. 74:1992;879-883.
31. Rami A., Krieglstein J. Protective effect of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609:1993;67-70.
32. Rowan S.A., Lake B.D. Tissue and cellular distribution of subunit c of ATP synthase in Batten disease (neuronal ceroid-lipofuscinosis). Am. J. Med. Genet. 57(2):1995;172-176.
33. Saito K., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium- activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA. 90:1993;2628-2632.
34. J. Sambrook, E.F. Fritsch, and T. Maniatis (1989) Molecular Cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
35. Siebert P.D., Larrick J.W. Competitive PCR. Nature. 359:1992;557-558.
36. Siman R., Baudry M., Lynch G. Regulation of glutamate receptor binding by the cytoskeletal protein fodrin. Nature. 313:1985;225-228.
37. Siman R., Noszek J.C. Excitatory amino acid activate calpain I and induce structural protein breakdown in vivo. Neuron. 4:1988;279-287.
38. Siman R., Noszek J.C., Kegerise C. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9:1989;1579-1590.
39. Siman R. Proteolytic mechanism for the neurodegeneration of Alzheimer's disease. Ann. NY Acad. Sci. 674:1992;193-202.
40. Suzuki K., Ohno S. Calcium activated neutral protease-structure-function relationship and functional implication. Cell Struct. Funct. 15:1990;1-6.
41. S. Watkins (1989) In situ hybridization and immunohistochemistry: cryosectioning. in: F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, K. Struhl (Eds.), Current Protocols in Molecular Biology, Suppl. 7, pp. 14.2.1-14.2.8.
42. Zimmerman U.J., Schlaepfer W.W. Calcium-activated neutral protease (CANP) in brain and other tissues. [Review]. Prog. Neurobiol. 23:1984;63-78.